Britt Vivian Christensen, PHARM D | |
218 E Highway 246, Buellton, CA 93427-9654 | |
(213) 742-6849 | |
Not Available |
Full Name | Britt Vivian Christensen |
---|---|
Gender | Female |
Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
Location | 218 E Highway 246, Buellton, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982244646 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 40187 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Britt Vivian Christensen, PHARM D Po Box 11720, Beverly Hills, CA 90213-4720 Ph: (310) 497-9811 | Britt Vivian Christensen, PHARM D 218 E Highway 246, Buellton, CA 93427-9654 Ph: (213) 742-6849 |
News Archive
The new seven-story headquarters of the David H. Koch Institute for Integrative Cancer Research at MIT, where scientists and engineers are working together to pursue new ways to treat, detect and prevent cancer, will be officially dedicated today at 4 p.m.
Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it's permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease.
The publication provides evidence of the durability and long term positive effect of Orthocell's Ortho-ATI™ tendon regeneration treatment for degenerate tendon injuries...
In the first study of its kind, researchers from five institutions from the UK and U.S. collaborating to determine the long-term outcomes of children with epilepsy found that outcomes varied despite similar short-term morbidity among the originally surveyed children when they were followed up within 10 years post-occurrence.
A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.
› Verified 9 days ago
Julia Ferriol, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 E Highway 246 Bldg 3, Buellton, CA 93427 Phone: 805-693-1132 | |
Ahmed Abdelazeem, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 E Highway 246 Bldg 3, Buellton, CA 93427 Phone: 805-693-1132 | |
Dr. Tamara Mitterer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 E Highway 246 # 3, Buellton, CA 93427 Phone: 805-693-1132 Fax: 805-683-1707 | |
Alexander Jasper Huynh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 E Highway 246 Bldg 3, Buellton, CA 93427 Phone: 805-693-1132 |